經導管心臟瓣膜市場(∼2017年):結構·技術性改善及有益的費用償還方案以推動治療數量的增加

經導管心臟瓣膜市場(∼2017年):結構·技術性改善及有益的費用償還方案以推動治療數量的增加 是由出版商GBI Research在2012年01月所出版的。 這份英文市場調查報告書包含Pages: 66 價格從美金3500起跳。

簡介

全球經導管心臟瓣膜市場在2010年到2017年間，預計將以年複合成長率22%擴大，一般預測該市場將從2010年的2億9300萬美金，達到2017年的11億9600萬美金的規模。

本報告提供全球經導管心臟瓣膜市場市場趨勢及競爭情形的相關調查，市場收益的實際成果與預測，市場機會及風險，開發平台分析，各國分析，並彙整主要企業簡介等，為您概述為以下內容。

第1章 目錄

第2章 簡介

第3章 全球經導管心臟瓣膜市場:市場特性評估

• 全球經導管心臟瓣膜市場收益:2007∼2010年
• 全球經導管心臟瓣膜市場收益:2010∼2017年
• 全球經導管心臟瓣膜市場收益:主要趨勢
• 全球經導管心臟瓣膜市場收益:市場動態

第4章 全球經導管心臟瓣膜市場:費用回本相關概要

第5章 全球經導管心臟瓣膜市場:機會與風險分析

第6章 全球經導管心臟瓣膜市場:開發平台分析

• 臨床實驗下，有未來潛力的藥物簡介
• Direct Flow Medical
• Heart Leaflet Technologies Valve
• Portico Transcatheter Heart Valve
• Engager
• PercValve

第7章 全球經導管心臟瓣膜市場:各國分析

• 整體市場分析
• 各國分析

第8章 全球經導管心臟瓣膜市場:市售的經導管心臟瓣膜比較及企業簡介

• 主要企業簡介

第9章 全球經導管心臟瓣膜市場:市售產品的主要的臨床實驗

第10章 全球經導管心臟瓣膜市場:合併情況

第11章 附錄

圖表

目錄

Scope

• Key geographies covered include the Germany, France, the UK, Spain, Italy, Australia and Brazil.
• The report includes information on transcatheter aortic heart valves market in countries where the technology has been introduced and is available.
• The report includes details about the key drivers and restraints that are shaping the global transcatheter heart valve market.
• The report also covers information on the leading market players and the competitive landscape.

Reasons to buy

• Develop business strategies by understanding the trends and developments that are driving the transcatheter heart valve market.
• Design and develop your product development, marketing and sales strategies.
• Capitalize on M&A opportunities by identifying key companies.
• Develop market entry and market expansion strategies.
• Identify the key companies that are best positioned to take advantage of emerging market opportunities.
• Exploit in-licensing and out-licensing opportunities by identifying the products most likely to ensure a robust return.
• Identify, understand the trends that are shaping the transcatheter heart valve market landscape.
• Make more informed business decisions from the insightful and in-depth analysis of the transcatheter heart valve market and the factors shaping it.

GBI Research's report, “Transcatheter Heart Valve Market to 2017 - Improvements in Design and Technique and a Favorable Reimbursement Scenario to Contribute to Higher Procedure Volumes“ provides information and analysis on the global Transcatheter heart valve market. The report provides market landscape, competitive landscape and information about market trends. The report provides comprehensive information on the key trends affecting the transcatheter heart valve market and key analytical content on the market dynamics. The report also reviews the competitive landscape and the profiles of companies operating on a global level. This report includes information only on transcatheter aortic heart valve market.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research's team of industry experts.

The global transcatheter heart valve market is expected to reach $1,196m in 2017. The market is forecast to grow with a Compounded Annual Growth Rate (CAGR) of 22% from $293.1m in 2010 to $1196m in 2017.

The market will be driven by the increasing elderly population as a proportion of the general population, as this is a group that is at particular risk of developing heart valve disease due to aortic stenosis. Degenerative calcified aortic stenosis is the most frequent heart valve disease in Europe and other Western countries. Calcification and thickening of the aortic valve is found to occur in 2-4% of adults over the age of 65. Transcatheter Aortic Valve Implantation (TAVI) provides elderly and high risk patients with a treatment option for heart valve replacement and the increasing elderly population is contributing to the growth of this market.

Currently, with more than 30 products in the pipeline, the transcatheter heart valve (THV) market is set to witness intense competition in the coming years. Though the first mover's advantage will be there for Edwards Lifesciences and Medtronic, the products in the pipeline are promising and are being developed with advanced features that the current products lack. Features such as valve retrievability and repositioning will be a part of a new generation of THVs. There are promising products from Boston Scientific (Lotus Valve), St. Jude Medical (Portico) and Direct Flow Medical (Direct Floe Medical Valve) which are still undergoing clinical trials. Products from these companies are expected to be launched in Europe during 2012-2014, which will intensify the competition in this market. Recently, JenaValve and ACURATE TA from JenaValve Technologies and Symetis respectively have been approved for commercial use in Europe.

The Sapien THV from Edwards Lifesciences was approved in November, 2011 by the US Food and Drug Administration (FDA). The approval was based on the evaluation of Cohort B of the Partner trial.

This approval paves for Edwards Lifesciences to market its THV in the US, where about 500,000 people suffer from severe aortic stenosis and about one third of this population will be ideal patients for a transcatheter heart valve replacement procedure. TAVR has already been adopted in Europe in a big way and the availability of this procedure in the US will increase the procedure volume in a big way. Also, once there is FDA approval, the procedure will gain acceptance in other parts of the globe where physicians and surgeons follow FDA recommendations.

Advancements in material, size and delivery systems have helped surgeons to refine the procedures, leading to better post-surgical outcomes. Improvements in delivery systems with reduced sheath size will reduce vascular complications.

Edwards Lifesciences has launched SAPIEN XT, which is an improved variant of the SAPIEN THV. This valve consists of a low profile delivery system and has several improved features when compared to the SAPIEN THV. Also driving better clinical outcomes are the advancements in imaging and fluoroscopy, which are an essential part of the procedure. Advancements in imaging software will enable greater precision and accuracy in valve insertion and offer better control in deployment and positioning. Improvements towards better valve and platform durability will enable expansion in indications for TAVI and this market will witness substantial growth in procedure volumes.

The availability of reimbursement for transcatheter heart valve replacement procedures has been a major driver for the adoption of this technique across Europe. The reimbursement scenario is different in countries across Europe. Germany has a universal system of reimbursement for TAVI, whereas France has conditional reimbursement. With many countries that previously did not have reimbursement in Europe now providing reimbursement, the adoption of TAVI is expected to increase.

Economic benefit analysis data from the PARTNER Cohort B trial and data on improved Quality of Life (QOL) has further increased the chances of several countries agreeing to provide reimbursement for TAVI. Favorable cost-effectiveness data along with the increasing clinical success of TAVI will be important factors that will drive further reimbursement coverage for TAVI, which in turn will drive the transcatheter heart valve market.

1. Table of Contents

• 1.1 List of Tables
• 1.2 List of Figures

2. Introduction

• 2.1 Overview
  • 2.1.1 Transcatheter Heart Valve Implantation
  • 2.1.2 Different Routes of Access
• 2.2 GBI Research Report Guidance

3. Global Transcatheter Heart Valve Market - Market Characterization

• 3.1 Global Transcatheter Heart Valve Market, Revenue ($m), 2007 - 2010
• 3.2 Global Transcatheter Heart Valve Market, Revenue ($m), 2010 - 2017
• 3.3 Global Transcatheter Heart Valve Market: Key Trends
  • 3.3.1 Concept of Hybrid Operating Rooms (OR) and Multi-disciplinary Team Approach is a Necessary Trend in the Development
  • 3.3.2 Major Cardiovascular Companies are on the Look-out for Small Companies with Transcatheter Heart Valve Replacement Technology to Strengthen their Portfolios
  • 3.3.3 Technology and Procedural Trends in the Future for Transcatheter Aortic Heart Valve Insertion (TAVI)
  • 3.3.4 Transcatheter Heart Valve Replacement - A New Dimension of Growth to the Global Heart Valve Market
• 3.4 Global Transcatheter Heart Valve Market: Market Dynamics
  • 3.4.1 Market Drivers
  • 3.4.2 Market Restraints

4. Global Transcatheter Heart Valve Market - Overview on Reimbursement

5. Global Transcatheter Heart Valve Market - Opportunity and Risk Analysis

6. Global Transcatheter Heart Valve Market - Pipeline Analysis

• 6.1 Profiles of Promising Products under Clinical Development
  • 6.1.1 Lotus Valve
• 6.2 Direct Flow Medical
  • 6.2.1 Product Description
  • 6.2.2 Clinical Trials
  • 6.2.3 Product Status
• 6.3 Heart Leaflet Technologies Valve
  • 6.3.1 Product Description
  • 6.3.2 Clinical Trials
  • 6.3.3 Product Status
• 6.4 Portico Transcatheter Heart Valve
  • 6.4.1 Product Description
  • 6.4.2 Clinical Trials
  • 6.4.3 Product Status
• 6.5 Engager
  • 6.5.1 Clinical Trials
  • 6.5.2 Product Status
• 6.6 PercValve
  • 6.6.1 Product Description
  • 6.6.2 Clinical Trials
  • 6.6.3 Product Status

7. Global Transcatheter Heart Valve Market - Country Analysis

• 7.1 Global Transcatheter Heart Valve Market: Cross-country Analysis
• 7.2 Historic and Forecast Revenue, By Country
  • 7.2.1 Transcatheter Heart Valve Market, Germany, Revenue ($m), 2007 - 2010
  • 7.2.2 Transcatheter Heart Valve Market, Germany, Revenue ($m), 2010 - 2017
  • 7.2.3 Transcatheter Heart Valve Market, France, Revenue ($m), 2007 - 2010
  • 7.2.4 Transcatheter Heart Valve Market, France, Revenue ($m), 2010 - 2017
  • 7.2.5 Transcatheter Heart Valve Market, UK, Revenue ($m), 2007 - 2010
  • 7.2.6 Transcatheter Heart Valve Market, UK, Revenue ($m), 2010 - 2017
  • 7.2.7 Transcatheter Heart Valve Market, Italy, Revenue ($m), 2007 - 2010
  • 7.2.8 Transcatheter Heart Valve Market, Italy, Revenue ($m), 2010 - 2017
  • 7.2.9 Transcatheter Heart Valve Market, Spain, Revenue ($m), 2007 - 2010
  • 7.2.10 Transcatheter Heart Valve Market, Spain, Revenue ($m), 2010 - 2017
  • 7.2.11 Transcatheter Heart Valve Market, Australia, Revenue ($m), 2007 - 2010
  • 7.2.12 Transcatheter Heart Valve Market, Australia, Revenue ($m), 2010 - 2017
  • 7.2.13 Transcatheter Heart Valve Market, Brazil, Revenue ($m), 2007 - 2010
  • 7.2.14 Transcatheter Heart Valve Market, Brazil, Revenue ($m), 2010 - 2017

8. Global Transcatheter Heart Valve Market - A Comparison of Commercially Available Transcatheter Heart Valves and Company Profiles

• 8.1 Global Transcatheter Heart Valve Market: Key Company Profiles
  • 8.1.1 Edwards Lifesciences
  • 8.1.2 Medtronic
  • 8.1.3 Jenavalve
  • 8.1.4 Symetis

9. Global Transcatheter Heart Valve Market - Key Clinical Trials of Marketed Products

• 9.1 PARTNER EU Trial
• 9.2 PARTNER US Trial
• 9.3 SOURCE Registry
• 9.4 18F TF CoreValve ReValving Post-marketing Registry Study
• 9.5 Symetis CE Approval Study
• 9.6 JenaValve CE Approval Study

10. Global Transcatheter Heart Valve Market - Consolidation Landscape

• 10.1 Key Deals 2007 - 2010
  • 10.1.1 Bracco Acquires HLT
  • 10.1.2 Boston Scientific Acquires Sadra Medical
  • 10.1.3 Medtronic Acquires Ventor
  • 10.1.4 Medtronic Acquires CoreValve
  • 10.1.5 Abbott Laboratories Acquires Evalve

11. Appendix

• 11.1 Definitions
  • 11.1.1 Transcatheter Heart Valves
• 11.2 Acronyms
• 11.3 Research Methodology
  • 11.3.1 Secondary Research
  • 11.3.2 Primary Research
  • 11.3.3 Models
  • 11.3.4 Forecasts
  • 11.3.5 Expert Panels
• 11.4 Contact Us
• 11.5 Disclaimer
• 11.6 Sources

• Table 1: Transcatheter Heart Valve Market, Global Market Revenue ($m), 2007 - 2010
• Table 2: Transcatheter Heart Valve Market, Global Market Revenue ($m), 2010 - 2017
• Table 3: Forecast Comparison of Different Types of Heart Valves, Revenue, ($m), 2011
• Table 4: Transcatheter Heart Valve Market, Global, List of Pipeline Products - I
• Table 5: Transcatheter Heart Valve Market, Global, List of Pipeline Products - II
• Table 6: Lotus Valve System - European Feasibility Study
• Table 7: Lotus Valve System - REPRISE I Trial
• Table 8: Direct Flow Medical Valve - European Feasibility And Safety Trial
• Table 9: Ventor Engager - Pivotal Trial
• Table 10: Transcatheter Heart Valve Market, Cross-country Analysis, 2011
• Table 11: Transcatheter Heart Valve Market, Germany, Revenue ($m), 2007 - 2010
• Table 12: Transcatheter Heart Valve Market, Germany, Revenue ($m), 2010 - 2017
• Table 13: Transcatheter Heart Valve Market, France, Revenue ($m), 2007 - 2010
• Table 14: Transcatheter Heart Valve Market, France, Revenue ($m), 2010 - 2017
• Table 15: Transcatheter Heart Valve Market, UK, Revenue ($m), 2007 - 2010
• Table 16: Transcatheter Heart Valve Market, UK, Revenue ($m), 2010 - 2017
• Table 17: Transcatheter Heart Valve Market, Italy, Revenue ($m), 2007 - 2010
• Table 18: Transcatheter Heart Valve Market, Italy, Revenue ($m), 2010 - 2017
• Table 19: Transcatheter Heart Valve Market, Spain, Revenue ($m), 2007 - 2010
• Table 20: Transcatheter Heart Valve Market, Spain, Revenue ($m), 2010 - 2017
• Table 21: Transcatheter Heart Valve Market, Australia, Revenue ($m), 2007 - 2010
• Table 22: Transcatheter Heart Valve Market, Australia, Revenue ($m), 2010 - 2017
• Table 23: Transcatheter Heart Valve Market, Brazil, Revenue ($m), 2007 - 2010
• Table 24: Transcatheter Heart Valve Market, Brazil, Revenue ($m), 2010 - 2017
• Table 25: SAPIEN, The PARTNER EU Trial
• Table 26: SAPIEN - The PARTNER US TRIAL
• Table 27: SAPIEN - The SOURCE Registry Trial (Cohort 1)
• Table 28: CoreValve Registry Trial
• Table 29: ACURATE TA, First In Man Trial
• Table 30: JenaValve, CE Mark Study

• Figure 1: Transcatheter Heart Valve Market, Global Market Revenue ($m), 2007 - 2010
• Figure 2: Transcatheter Heart Valve Market, Global Market Revenue ($m), 2010 - 2017
• Figure 3: Transcatheter Heart Valve Market, Global, Consolidation Snap Shot, 2011
• Figure 4: Transcatheter Heart Valve Market, Global, Advancements in Technology and Procedures, 2011
• Figure 5: Studies Showing Percentage of Patients with Severe Aortic Stenosis without Treatment, 2011
• Figure 6: Percentage of Elderly Population, Global, 2011 -2020
• Figure 7: Cost Effectiveness Analysis: Transcatheter Heart Valve Implantation (TAVI) vs. Surgical Aortic Valve Replacement (SAVR), PARTNER Cohort A Results
• Figure 8: Transcatheter Heart Valves, Global, Details of Few Pipeline Products
• Figure 9: Transcatheter Heart Valves - Expected Market Events of Key Pipeline Products
• Figure 10: Transcatheter Heart Valve Market, Global Opportunity and Risk Analysis, 2011
• Figure 11: Comparison of Different Types of Heart Valves, Forecast, Revenue, ($m), 2011
• Figure 12: Transcatheter Heart Valve Market, Global, Number of Pipeline Products by Company, 2011
• Figure 13: Transcatheter Heart Valve Market, Cross-country Analysis, 2011
• Figure 14: Transcatheter Heart Valve Market, Germany, Revenue ($m), 2007 - 2010
• Figure 15: Transcatheter Heart Valve Market, Germany, Revenue ($m), 2010 - 2017
• Figure 16: Transcatheter Heart Valve Market, France, Revenue ($m), 2007 - 2010
• Figure 17: Transcatheter Heart Valve Market, France, Revenue ($m), 2010 - 2017
• Figure 18: Transcatheter Heart Valve Market, UK, Revenue ($m), 2007 - 2010
• Figure 19: Transcatheter Heart Valve Market, UK, Revenue ($m), 2010 - 2017
• Figure 20: Transcatheter Heart Valve Market, Italy, Revenue ($m), 2007 - 2010
• Figure 21: Transcatheter Heart Valve Market, Italy, Revenue ($m), 2010 - 2017
• Figure 22: Transcatheter Heart Valve Market, Spain, Revenue ($m), 2007 - 2010
• Figure 23: Transcatheter Heart Valve Market, Spain, Revenue ($m), 2010 - 2017
• Figure 24: Transcatheter Heart Valve Market, Australia, Revenue ($m), 2007 - 2010
• Figure 25: Transcatheter Heart Valve Market, Australia, Revenue ($m), 2010 - 2017
• Figure 26: Transcatheter Heart Valve Market, Brazil, Revenue ($m), 2007 - 2010
• Figure 27: Transcatheter Heart Valve Market, Brazil, Revenue ($m), 2010 - 2017
• Figure 28: Comparison of Commercially Available Transcatheter Heart Valves, 2011
• Figure 29: Edwards Lifesciences, PARTNER Trial, Study Design

相關商品

導管相關市場調查報告書

亞太地區的經導管栓塞·阻塞設備市場:2012年
Asia Pacific Markets for Transcatheter Embolization and Occlusion Devices 2012
價格 : US $ 6995
出版日期 : 2012年04月

歐洲的藥劑溶出性血管支架市場:2011年∼2015年
Drug-eluting Stent Market in Europe 2011-2015
價格 : US $ 1500
出版日期 : 2012年04月

全球支架血管市場：2011年∼2015年
Global Stent Grafts Market 2011-2015
價格 : US $ 1500
出版日期 : 2012年04月

GBI Research發行的醫療設備相關市場調查報告書

腎臟透析設備市場(∼2017年):低成本及與血液透析機同樣的效率，增加了腹膜透析的引進率

Renal Dialysis Equipment Market to 2017- Lower Costs and Similar Efficacy Rates as Hemodialysis to Increase Adoption Rates of Peritoneal Dialysis

價格 : US $ 3500

出版日期 : 2012年04月

病患監測設備市場(∼2017年):無線遠端患者監護的利用率增加，是技術趨勢的關鍵

Patient Monitoring Devices Market to 2017 - Increasing Use of Wireless Remote Patient Monitoring to be the Key Technology Trend

價格 : US $ 3500

出版日期 : 2012年03月

醫療用影像資訊系統市場(∼2017年):舊系統的更換和軟體的進步顯示出成長的機會

Medical Imaging Information Systems Market to 2017 - Replacement of Legacy Systems and Advances in Software Present Growth Opportunities

價格 : US $ 3500

出版日期 : 2012年03月

Email Alert(Email 通知) - 最新市場調查報告書

GII 將每天定期更新最新市場調查報書資訊，選擇您有興趣的市場分類，我們將用Email的方式讓您收到最新訊息!